A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors
Bristol-Myers Squibb
Bristol-Myers Squibb
7 Hills Pharma, LLC
Pfizer
Aulos Bioscience, Inc.
Bristol-Myers Squibb
3D Medicines
BeOne Medicines
Merck Sharp & Dohme LLC
GI Innovation, Inc.
AstraZeneca
Genmab
Oncorena AB
Neonc Technologies, Inc.
Merck Sharp & Dohme LLC
Genenta Science
Merck Sharp & Dohme LLC
Ocellaris Pharma, Inc.
iOmx Therapeutics AG
Inhibrx Biosciences, Inc
Bristol-Myers Squibb
Regeneron Pharmaceuticals
CRISPR Therapeutics
NiKang Therapeutics, Inc.
Regeneron Pharmaceuticals
Dragonfly Therapeutics
ITM Oncologics GmbH
Arsenal Biosciences, Inc.
Scancell Ltd
Vyriad, Inc.
GI Innovation, Inc.
A2 Biotherapeutics Inc.
Incyte Corporation
Beijing Scitech-Mq Pharmaceuticals Limited
Adicet Therapeutics
Incyte Corporation
Merck Sharp & Dohme LLC
Medicenna Therapeutics, Inc.
OncoC4, Inc.
Mural Oncology, Inc
Kymab Limited
Portage Biotech
Nimbus Therapeutics
GI Innovation, Inc.
Simcha IL-18, Inc.
23andMe, Inc.
Shanghai PerHum Therapeutics Co., Ltd.
Salubris Biotherapeutics Inc
X4 Pharmaceuticals
NGM Biopharmaceuticals, Inc
GlaxoSmithKline